Fw: Ref.: (LML) 150th Years Anniversary Conference at Bergen

 

 

 
Leprosy Mailing List – February 23 ,  2023

 

Ref.:  (LML) 150th Years Anniversary Conference at Bergen

 

From:  Ben Naafs, Munnekeburen, the Netherlands

---

 

We received the following announcement through Dr. Ben Naafs:

WEBCAST: The 150th Anniversary of the Discovery of M. Leprae ~ A Look at the Past, Present and Future of Leprosy (Hansen's Disease) ~

 

https://sasakawaleprosyinitiative.org/latest-updates/initiative-news/3257/

 

February 28th, 1873, was the day Dr. Gerhard Armauer Hansen first wrote in his notebook that he had observed rod-shaped bacteria in samples from patients affected by leprosy. The bacillus in question was later given the name Mycobacterium leprae—leprosy's causative agent. The discovery is a watershed moment in the history of leprosy and global health—a scientific breakthrough that had enormous consequences.

The anniversary of Hansen's discovery will not be used to glorify the past. Rather, we take this opportunity to critically assess past achievements, take stock of the situation today, and address the future steps needed to rid the world of this ancient, misunderstood, and treatable disease.

What has happened since the discovery of M. leprae in Bergen 150 years ago, what is happening now, and what does the future hold? How is this history preserved, how it is communicated, and why is the history of leprosy important to its future?

WEBCAST Registration

Date: February 28, 2023

Care, University of Bergen, Norway 

Time: 21:00-22:15 (JST), 13:00-14:15 (CET), 12:00-13:15 (UTC)
Length: 75 min.
Language: English
Organizers: University of Bergen, Sasakawa Leprosy (Hansen's Disease) Initiative
Moderator: Prof. Magnus Vollset, Associate Professor, History of medicine, History of science, Department of Global Public Health and Primary Care, University of Bergen, Norway

---

---

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/49137aa2-b3e2-45f2-919e-b1177b2e76f4n%40googlegroups.com.

Fw: Ref.: (LML) IAL Textbook of Leprosy - 3rd Edn. (2023)

 

Leprosy Mailing List – February 19,  2023

 

Ref.:  (LML) IAL Textbook of Leprosy - 3rd Edn. (2023)

From:  Bushan Kumar, Sunil Droga and HK Kar, India

 

Dear Dr. Schreuder & colleagues, 

 

We are pleased to inform you that IAL Textbook of Leprosy (3rd Edn.) released during the "International Leprosy Congress" Hyderabad (Nov 2022) is now available for sale in market and online stores.

Salient Features…. 

• Covers all possible aspects of leprosy, tracing its history, epidemiology, immunogenetics, bacteriology of Mycobacterium leprae, immunology, pathology, mechanisms of nerve damage, disease classification, clinical and laboratory diagnosis, differential diagnosis, chemotherapy, lepra reactions, neuritis and their management, National Leprosy Eradication Programme (NLEP) & future prospects.
  
  
  
• Includes chapters related to basics of history taking and techniques of clinical and nerve examination, ocular leprosy, vaccines (immuno-prophylaxis, immunotherapy), chemoprophylaxis, deformities and their management, recording and assessment of nerve involvement and experimental leprosy.
  
  
  
• Covers special situations, viz. leprosy in children, pregnancy, associated with HIV, immune-compromised hosts including Covid-19 and issues related to community–based rehabilitation, psychosocial aspects, stigma, and migration. 
  
  
  
• Presents lucid and comprehensive information, and clinical pictures / images help to diagnose leprosy even in low endemic situations.
  
  
  
• Discusses problems of drug resistance, relapse, challenges and scenario beyond 2030. Highlights the role of NGOs in the leprosy control program, and the case histories give a reassuring and encouraging picture which adds to the optimism and presents a new face of leprosy considering the achievements in control of leprosy. 
  
  
  
• Contains the most up-to-date and comprehensive material contributed by 87 acclaimed experts of national and international repute. 
  
  
  
• Photo gallery gives good visual impression of how the disease looks in different shades of skin color. 
  
  
  
• Improves the diagnostic accuracy with the help of nearly 530 figures and 130 tables and graphs that capture the presentation of leprosy in practice.
  
  
  
• Enhances clinical and therapeutic knowledge with the latest on diagnosis and other research areas in leprosy. Ideal book for dermatologists, leprologists, internists, epidemiologists, social scientists, laboratory and research personnel, teachers and students, national and international NGOs, World Health Agencies  and the Health Ministries.   

Warm regards,

Prof. Bushan Kumar, Prof. Sunil Droga, Prof. HK Kar

Editors

 

AMAZON : https://www.amazon.in/textbook-Leprosy-Hemanta-Kumar-Bhushan/dp/9354654541/ref=sr_1_2?crid=PXJ5BA5YUQMJ&keywords=ial+textbook+of+leprosy&qid=1676644693&sprefix=IAL+Text%2Caps%2C627&sr=8-2            

Jaypee Portal: https://www.jaypeebrothers.com/pgDetails.aspx?cat=s&book_id=9789354654541  

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/a95ce4ef-93d7-4d70-b924-f4fe44d40fb4n%40googlegroups.com.

Fw: (LML) WHO Goodwill Ambassador's Leprosy Bulletin NO. 113, February 2023

 

 
Leprosy Mailing List – February 17,  2023

 

Ref.:  (LML) WHO Goodwill Ambassador's Leprosy Bulletin NO. 113, February 2023

From:  Takahiro Nanri, Tokyo, Japan

 

 

Dear Dr. Schreuder and Friends,  

 

Warm greetings from Sasakawa Health Foundation/Sasakawa Leprosy (Hansen's Disease) Initiative in Tokyo.

 

We have issued WHO Goodwill Ambassador's Leprosy Bulletin NO. 113 February 2023 "Starting 2023 with commitment to leaving no one behind". In this issue, we feature: 

 

MESSAGE FROM THE AMBASSADOR
On Jan. 23-24, 2023, the International Symposium at the Vatican on Hansen's Disease was held at the Augustinian Patristic Institute, in cooperation with the Dicastery for Promoting Integral Human Development, on the theme "Leave No One Behind."   Read More 

 

VIEWPOINT

New Team Leader of WHO's Global Leprosy Programme shares vision

Dr. Vivek Lal, Team Leader of Global Leprosy Programme, World Health Organization (WHO)
Towards a world with zero leprosy: WHO is committed to supporting leprosy-affected countries to achieve zero leprosy disease, zero leprosy disability, and zero leprosy stigma and discrimination by 2030 — the vision of the WHO Global Leprosy Strategy 2021–2030.  Read more 

 

ANNOUNCEMENT
Anniversary events being organized in Bergen, Norway, 150 years after Hansen's discovery

Magnus Vollset, Associate Professor, Department of Global Public Health and Primary Care, University of Bergen

On the evening of Feb. 28, 1873, Gerhard Armauer Hansen observed, for the very first time, small rod-shaped organisms in tissue samples from one of his patients.  Read more 

 

REPORT
International Symposium at the Vatican on Hansen's Disease held in Rome in January

On Jan. 23-24, 2023, the International Symposium at the Vatican on Hansen's Disease was held at the Augustinian Patristic Institute (Augustinianum) in Rome on the theme "Leave No One Behind.  Read more 

 

REPORT
Pope Francis calls for renewed commitment to building an inclusive society

"Pope," meaning "father," is the honorary title for the bishop of Rome, head of the Roman Catholic Church and Vatican City and leader of an estimated 1.3 billion Catholics worldwide.   Read more 

 

SPOTLIGHT
About the Dicastery for Promoting Integral Human Development

In his closing speech, Monsignor Charles Namugera noted that over the two days of the International Symposium at the Vatican on Hansen's Disease, some people would look at "Dicastery for Promoting Integral Human Development" on his name tag and ask, puzzled, what is that about? Read more 

 

REPORT
What's next? Symposium voices on the issues and how to move forward

On Jan. 23-24, 2023, the International Symposium at the Vatican on Hansen's Disease was held at the Augustinian Patristic Institute (Augustinianum) in Rome on the theme "Leave No One Behind.  Read more 

 

AMBASSADOR'S JOURNAL

Audience with Pope Francis
On Jan. 26, 2023, while in Rome to attend the International Symposium at the Vatican on Hansen's Disease, WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa had an audience with Pope Francis at the Apostolic Palace in Vatican City.  Read more 

 

WISHLIST

Pragnya Ayyagari, Miss Supranational India 2023
The Leprosy Bulletin occasionally asks a person affected by leprosy or an individual involved in leprosy-related work for a list of things that they wish could happen. We ask contributors to be bold in order to stimulate thinking and inspire new approaches. Read more

 

BACK ISSUES 
We hope that you would enjoy reading the latest Leprosy Bulletin. 

 

Takahiro NANRI, Ph.D.
Executive Director, Sasakawa Health Foundation

*********************************************************
Sasakawa Leprosy (Hansen's Disease) Initiative
Sasakawa Health Foundation
Tel：81-3-6229-5377, Fax：81-33-6229-5388
email: hansen@shf.or.jp
website: https://sasakawaleprosyinitiative.org/,  https://www.shf.or.jp
*********************************************************

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/94f81ecc-fb0d-498e-b010-a8ba19d4df27n%40googlegroups.com.

Fw: Ref.: (LML) Infolep monthly review of new publications on leprosy, February 2023

Leprosy Mailing List – February 7,  2023

 

Ref.:  (LML) Infolep monthly review of new publications on leprosy, February 2023

 

From:  Roos Geutjes and Marente Mol, Amsterdam, the Netherlands

 

Dear colleagues, 

Many thanks to everyone who helped to raise awareness on World Leprosy Day and World NTD Day! On World NTD Day, the Kigali Declaration Commitment Tracker was launched to capture and monitor resources invested in NTD programmes, and to track commitments made by partners.

The Royal Society of Tropical Medicine and Hygiene has launched a call for papers on mental health, stigma and NTDs. Make sure to submit your manuscript timely, before the 30th of April!

More information on this, along with other news and events, can be found at the bottom of this newsletter.

Enjoy reading the latest publications that are listed below. Feel free to contact us to receive the full-text versions when these cannot be found on Infolep. We would also be happy to assist you with literature searches. 

Warm regards,

Roos Geutjes & Marente Mol

www.leprosy-information.org
info@infolep.org
 

 

 

Highlighted

 

Sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases: hybrid meeting, 27-28 September 2022  
World Health Organization. 2022.
 

G-FINDER 2022 - Neglected disease research and development: The status quo won't get us there
Policy Cures Research. 2023.
 

A compendium of indicators for monitoring and evaluating progress of the road map for neglected tropical diseases 2021–2030
World Health Organization. 2022.
 

 

 

New publications

Feel free to contact us to receive full-text versions if these cannot be found through the Infolep portal.

 

Meaningful Engagement of Persons Affected by Leprosy in Research: An Exploration of Its Interpretation, Barriers, and Opportunities
de Groot L, van 't Noordende AT, Duck M, et al. Tropical Medicine and Infectious Disease. MDPI AG. 2023; 8 (1) : 52. 
 

World Health Organization strategic framework for integrated control and management of skin-related neglected tropical diseases: what does this mean for dermatologists?
Yotsu RR, Fuller LC, Murdoch ME, et al. British Journal of Dermatology. Oxford University Press (OUP). 2022.
 

Technology for world elimination of neglected tropical diseases
The Lancet Digital Health . The Lancet Digital Health. Elsevier BV. 2023; 5 (2) : e51.
 

The Impact of Community Based Rehabilitation (CBR) on Education of Persons with Disabilities in Plateau State
Lalu JD, Ozegya A, Yakubu AF. KIU Journal of Humanities. 2023; 7 (4) : 89-104.
 

Community Health Workers: what do international studies tell us?
Méllo LMBDDE, Santos RCD, Albuquerque PCD. Ciência &amp; Saúde Coletiva. FapUNIFESP (SciELO). 2023; 28 (2) : 501-520.
 

Restricted participation: Drivers, experiences and implications of disability stigma in Ethiopia  
Breffka E, Jagoe C, Murphy SP, et al. African Journal of Disability. 2023.
 

Progressive neuropathy in patients with lepromatous leprosy after multidrug therapy.
Penna P, Pitta I, Vital R, et al. Memorias do Instituto Oswaldo Cruz. 2023.
 

Clusters of risk for the occurrence of leprosy and disabilities in children under 15 years of age in Cuiabá: a geospatial study
Martoreli Júnior JF, Ramos ACV, Berra TZ, et al. Revista Brasileira de Epidemiologia. FapUNIFESP (SciELO). 2023.
 

Epidemiological characteristics of leprosy during the period 2005-2020: A retrospective study based on the Chinese surveillance system.  
Li X, Jin G, Yang J, et al. Frontiers in public health. 2022.
 

Pathogenesis, clinical manifestations, and treatment of leprosy  
Mennuru NB, Birudala R, Birudala G. Viral, Parasitic, Bacterial, and Fungal Infections. Elsevier. 2023.
 

Clinico-sociodemographic Profile of Leprosy Neuropathy in Medan, Indonesia
Dalimunthe DA, Sinambela DWI, Lubis SR. Journal of Pakistan Association of Dermatologists. 2023; 33 (1) : 142-148.
 

Intra‐cranial involvement of trigeminal nerve in a patient with borderline tuberculoid leprosy in type 1 lepra reaction  
Sharma A, Narang T, Mehta H, et al. Australasian Journal of Dermatology. Wiley. 2023.
 

O papel da atenção primária na rede de atenção à saúde frente ao manejo da hanseníase: um estudo transversal  
de Souza MH, de Araújo MCM, de Lima VPB, et al. Revista de APS. 2023; 25 (2) : 343-364.
 

 

Assessment of neuropathic pain, functional activity limitation and quality of life of people affected by leprosy in an endemic area in Northeast Brazil: a cross-sectional study.  
Silva S, de Souza S, Santana M, et al. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2023.
 

Silent peripheral neuropathy determined by high-resolution ultrasound among contacts of patients with Hansen's disease.  
Voltan G, Marques-Junior W, Santana J, et al. Frontiers in medicine. 2022.
 

Long-term presence of autoantibodies in plasma of cured leprosy patients  
Yang X, Dong H, Kuang Y, et al. Scientific Reports. Springer Science and Business Media LLC. 2023.
 

Effects of Citric Acid on the Healing Process of Chronic Wound due to Leprosy
Passos JRD, Sangaleti CT, Trincaus MR, et al. The International Journal of Lower Extremity Wounds. SAGE Publications. 2023.
 

Performance of the Health System Network in Formosa Argentina, in the Diagnosis of Leprosy
Arnaiz MR, Abarca DT, Santini MS, et al. The American Journal of Tropical Medicine and Hygiene. American Society of Tropical Medicine and Hygiene. 2023.
 

Effect of adipose derived stromal vascular fraction on leprosy neuropathy: A Preliminary report  
Sirait SP, Bramono K, Menaldi SL, et al. PLOS Neglected Tropical Diseases. Public Library of Science (PLoS). 2023; 17 (1) : e0010994.
 

The efficacy of topical adipose mesenchymal stem cell-conditioned medium versus framycetin gauze dressing in chronic plantar ulcer of leprosy: A randomized controlled trial.
Alinda M, Christopher P, Listiawan M, et al. Indian journal of dermatology, venereology and leprology. 2022.
 

Assessment of key regulatory genes and identification of possible drug targets for Leprosy (Hansen's disease) using network-based approach.  
Khan M, Khan S, Lohani M, et al. Biotechnology & genetic engineering reviews. 2023.
 

Resistance to anti-leprosy drugs: A cross-sectional study from a tertiary care hospital in Puducherry.
Manjula B, Gopinath H, Karthikeyan K. Indian journal of dermatology, venereology and leprology. 2022.
 

Modified tarsorrhaphy versus gold weight implant technique for paralytic lagophthalmos treatment in patients with leprosy: One-year observation of a randomized controlled trial study  
Irawati Y, Natalia MER, Gondhowiardjo TD, et al. Frontiers in Medicine. Frontiers Media SA. 2023.
 

Impact of nanoparticles on amyloid beta-induced Alzheimer's disease, tuberculosis, leprosy and cancer: A systematic review.  
Chakraborty A, Mohapatra S, Barik S, et al. Bioscience reports. 2023.
 

 

 

 

News & Events

 

First WHO Global Meeting on Skin NTDs
27-31 March, 2023
 

The WHO Department of Control of NTDs is organizing the First WHO Global Meeting on Skin NTDs at WHO Headquarters in Geneva, Switzerland. The meeting will be hybrid (in person and online) and will be conducted in English, French and Spanish with simultaneous interpretation. There will be oral presentations and posters and a book of abstracts will be published.
 

Call for papers: Mental health, stigma and Neglected Tropical Diseases 

The Royal Society of Tropical Medicine and Hygiene has launched a call for papers on mental health, stigma and NTDs, to be published in a supplement of International Health. The aim of the supplement is to reflect on achievements and challenges to date, to collate current research and lessons learned, and to outline ambitions for policy engagement to drive further progress in the field. Deadline of submission is 30 April, 2023. 
 

Kigali Declaration Commitment Tracker 

A new interactive online tool has been launched to help track global resources to end NTDs. The Kigali Declaration Commitment Tracker is designed to capture, track and monitor commitments to the Kigali Declaration on NTDs. It enables partners in the NTD community to understand the volume of resources being invested in NTD programmes and to hold endorsers of the declaration accountable for the commitments they made. 
 

World NTD Day 2023 Webinar 

The WHO and Uniting to Combat NTDs organised a webinar to celebrate World NTD Day on 30 January, 2023. In case you missed the event, the recording of the full webinar is available on Youtube. 
 

World Health Day
7 April, 2023

World Health Day is celebrated annually and draws attention to a specific health topic of concern to people all over the world. This year, the World Health Organization will observe its 75th birthday. 

 

 

Global Appeal 2023 | Sasakawa Health Foundation 

The Global Appeal 2023 to End Stigma and Discrimination against Persons Affected by Leprosy and the International Symposium at the Vatican on Hansen's Disease took place on 23-24 January, 2023. All recorded sessions are available on the website.
 

Maximising the untapped potential of NTD platforms to reach marginalised communities during future global health crises.
8 February, 2023

How can community NTD services and delivery mechanisms be leveraged to promote risk reduction behaviours and prevent misinformation amongst hard-to-reach communities during future pandemic responses? This COR-NTD Research Link session will highlight key lessons to take forward, and to adapt programme and emergency responses to future global crises.
 

Achieving the WHO 2030 NTD Roadmap goals: systems and data-driven approaches to improve program strategy, planning and implementation for the elimination of PC-NTDs
22 February, 2023

This COR-NTD Research Link session seeks to focus on the shifts in approaches used to address NTDs as outlined in the WHO 2030 Roadmap. This session will provide a real-world example of integration as experienced by the Ethiopia NTD programme. Further, the session will illustrate gaps, approaches and best practices for the overall data process for NTDs - data availability and access, analysis and visualization and data use and feedback. 
 

RSTMH Early Career Grants Programme

The RSTMH 2023 Early Career Grants Programme opened for applications from early career researchers and global health professionals based anywhere in the world. Projects can be on any topic related to tropical medicine and global health, from across the research spectrum of lab, translation, implementation and policy. 

 

 

Links

 

Info Hansen - A innovative hub for knowledge sharing about Hansen's Disease
 

ALLF - Official website of the Association des Léprologues de Langue Française
 

LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in leprosy to share ideas, information, experiences and questions
 

InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)

 

ILEP newsletter archive

GPZL newsletter subscription

WHO Goodwill Ambassador's Leprosy Bulletin

Leprosy Review

Leprosy Review Repository (1928-2001)

Fontilles Revista de Leprología

Indian Journal of Leprosy

Hansenologia Internationalis

 

GDPR & the Infolep newsletter

 
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our privacy statement and mailing list.

Infolep sends out monthly e-mails with an overview of recent publications on leprosy and related issues. The purpose of this activity is to keep subscribers up to date.

Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.

You can update your preferences or unsubscribe from this list at any time.

 

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/b600d251-cc49-4428-8354-45aa915bdc1an%40googlegroups.com.